Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.440
+0.070 (2.95%)
At close: Nov 22, 2024, 4:00 PM
2.450
+0.010 (0.41%)
After-hours: Nov 22, 2024, 6:08 PM EST
Editas Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -210.57 | -153.22 | -220.43 | -192.5 | -115.98 | -133.75 | |
| Depreciation & Amortization | 5.89 | 6.06 | 6.34 | 5.05 | 3.96 | 2.83 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 27.5 | - | |
| Loss (Gain) From Sale of Investments | -7.03 | -4.82 | -0.72 | 1.66 | -16.37 | - | |
| Stock-Based Compensation | 22.74 | 19.8 | 29.29 | 43.4 | 23.16 | 27.24 | |
| Other Operating Activities | 1.18 | 1.6 | - | - | 0.1 | -2.93 | |
| Change in Accounts Receivable | 2.3 | -5.04 | -4.88 | 5.78 | -5.63 | -0.39 | |
| Change in Accounts Payable | 2.12 | -1.49 | 4.37 | -1.14 | 0.86 | 0.27 | |
| Change in Unearned Revenue | - | - | -3.33 | -22.71 | -91.79 | 55.4 | |
| Change in Other Net Operating Assets | 3.05 | 4.94 | 12.02 | -3.35 | -5.65 | 10.65 | |
| Operating Cash Flow | -181.76 | -132.18 | -177.35 | -163.8 | -179.84 | -40.67 | |
| Capital Expenditures | -9.59 | -4.72 | -4.12 | -7.98 | -7.16 | -6.17 | |
| Sale of Property, Plant & Equipment | - | - | 0.02 | - | 0.01 | 0.1 | |
| Investment in Securities | 203.62 | 0.99 | 118.17 | -46.49 | -133.37 | 18.32 | |
| Investing Cash Flow | 194.03 | -3.73 | 114.07 | -54.47 | -140.52 | 12.25 | |
| Issuance of Common Stock | 1.03 | 118.04 | 1.28 | 282.11 | 224.12 | 131.82 | |
| Financing Cash Flow | 1.03 | 118.04 | 1.28 | 282.11 | 224.12 | 131.82 | |
| Net Cash Flow | 13.29 | -17.87 | -62 | 63.84 | -96.24 | 103.41 | |
| Free Cash Flow | -191.36 | -136.9 | -181.47 | -171.78 | -187.01 | -46.84 | |
| Free Cash Flow Margin | -309.84% | -175.23% | -920.59% | -672.49% | -206.11% | -228.12% | |
| Free Cash Flow Per Share | -2.33 | -1.80 | -2.64 | -2.54 | -3.19 | -0.94 | |
| Levered Free Cash Flow | -113.8 | -87.81 | -102.27 | -85.55 | -77.36 | -46.79 | |
| Unlevered Free Cash Flow | -113.8 | -87.81 | -102.27 | -85.55 | -77.36 | -46.79 | |
| Change in Net Working Capital | -9.99 | 3.21 | -7.44 | 5.31 | 13.04 | -17.38 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.